B&C News: Synthetic Biology

January 11, 2017
The Top Chemical Regulatory Stories of 2016
  The attorneys, scientists, policy experts, and regulatory advisors of Bergeson & Campbell, P.C. (B&C®), The Acta Group (Acta®), and B&C® Consortia Management, L.L.C. (BCCM) endeavor year-round to keep you informed on key developments as they happen, and prepared for looming changes and deadlines, to help you maintain compliance and competitive advantage as you market your products throughout the world. As the new year begins, we offer you this look back at the top stories of 2016 (as measured by clicks, reads, and shares by readers of our blogs and e-mails), a ... read more >
June 6, 2016
Lynn L. Bergeson Presents “Sustainable Agriculture and Food Security in the Mediterranean Region: Modern Agriculture and Technology” at the International Bar Association 4th Mediterranean Conference
On June 6, 2016, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell P.C., (B&C®), presented “Sustainable Agriculture and Food Security in the Mediterranean Region: Modern Agriculture and Technology” at the International Bar Association 4th Mediterranean Conference in Rome, Italy. Ms. Bergeson began her presentation with a discussion of the similarities between U.S. and European Union (EU) oversight systems. Both systems address comprehensively potential risks posed by evolving agricultural technologies through a complex web of horizontal and vertical laws. ... read more >
November 30, 2015
Federal Biotech Regulations Confusing; Diverse Parties Agree on Little Else
A November 30, 2015 story in Bloomberg BNA Daily Environment Report on the federal approach to regulating bioengineered products and comments submitted by nearly a thousand organizations and individuals on the Coordinated Framework for the Regulation of Biotechnology, featured commentary from B&C: Bergeson & Campbell PC, a law firm that represents companies working with emerging technologies, supported the efforts to update the framework but described structural problems that may thwart the White House’s intentions. The regulatory infrastructure is ... read more >
November 25, 2015
Diverse Parties Say Federal Biotech Rules Confusing
The November 25, 2015, Bloomberg BNA Daily Environment Report quoted Bergeson & Campbell, P.C., in the article “Diverse Parties Say Federal Biotech Rules Confusing.” Bergeson & Campbell PC, a law firm that represents companies working with emerging technologies, supported the efforts to update the framework but described structural problems that may thwart the White House's intentions. The regulatory infrastructure is ill-suited to address synthetic biology—a new form of genetic engineering—nimbly or comprehensibly, the law firm wrote. Some synbio ... read more >
November 6, 2015
Inside EPA Includes Comments From Richard E. Engler, Ph.D. In Article “Agencies Receive Conflicting Comments On Update Of Biotech Reviews”
On November 6, 2015, Inside EPA included comments made by Richard E. Engler, Ph. D. at a public meeting held by EPA, USDA, and FDA to  update the federal coordinated framework for how the three agencies regulate biotechnology. […]Industry officials, meanwhile, emphasized biotechnology's growing importance in food production and cautioned that over-regulation will stifle innovation. Officials with Dupont and the law firm Bergeson & Campbell, P.C., which represents industry clients, called for science-based assessments that consider products' risks and ... read more >
November 2, 2015
BNA Daily Environment Report Article “New Authority Not Expected for Biotech Framework Update,” Quotes Richard E. Engler, Ph.D.
The November 2, 2015, BNA Daily Environment Report article, “New Authority Not Expected for Biotech Framework Update,” included comments made by Richard E. Engler, Ph.D. at the “Modernizing the Regulatory System for Biotechnology Products” public meeting held by FDA, USDA, and EPA.     […DuPont global director of corporate regulatory affairs Terry] Medley and Richard Engler, a senior chemist working for Bergeson & Campbell P.C., said the update needs to provide public confidence in the regulatory oversight process, so that the public can ... read more >
October 26, 2015
Inside EPA Quotes Lynn L. Bergeson in article “TSCA Reform Legislation Could Smooth Path For New Biotechnologies”
The October 26, 2015, Inside EPA article, “TSCA Reform Legislation Could Smooth Path For New Biotechnologies,” included comments made by Lynn L. Bergeson at an event hosted by the Wilson Center’s Synthetic Biology Project (synbio). Pending legislation in Congress to reform the 40-year-old Toxic Substances Control Act (TSCA) could make it easier for EPA to assess the potential risks of new technologies, such as synthetic biology, and review requests to undertake field research or commercialize new products, an industry attorney says. While the legislation does not ... read more >
October 20, 2015
Leveraging Synthetic Biology’s Promise and Managing Potential Risk
On October 15, 2015, Bergeson & Campbell, P.C. (B&C®) and the Woodrow Wilson International Center for Scholars (Wilson Center) hosted “Leveraging Synthetic Biology’s Promise and Managing Potential Risk,” a panel discussion featuring Lynn L. Bergeson, Sheryl Lindros Dolan, and Richard E. Engler, Ph.D., of B&C, and Todd Kuiken, Ph.D., Senior Program Associate, Synthetic Biology Project, Wilson Center. The event coincided with the release of “The DNA of the U.S. Regulatory System: Are We Getting It Right For Synthetic Biology?,” authored by the ... read more >
October 9, 2015
Bergeson & Campbell, P.C. and the Wilson Center Release Report on Synthetic Biology's Challenge to U.S. Regulatory Systems
  Panel Discussion to Be Held Wednesday, October 15, 2015, from 12:00 p.m. - 2:00 p.m. (EDT)   On October 15, 2015, the Woodrow Wilson International Center for Scholars (Wilson Center) will host "Leveraging Synthetic Biology's Promise and Managing Potential Risk," a panel discussion featuring Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), and Todd Kuiken, Ph.D., Senior Program Associate, Synthetic Biology Project, Wilson Center. The event coincides with the release of "The DNA of the U.S. Regulatory System: Are We Getting It ... read more >
September 3, 2015
Bergeson & Campbell, P.C. Quoted in Inside EPA Article “New EPA Guide Aims To Improve Synthetic Biology Algae Project Reviews”
A September 3, 2015, Inside EPA article regarding EPA’s efforts to improve how it reviews companies’ proposals to develop synthetic biology products, and specifically biotech algae, featured quotes from Bergeson & Campbell, P.C.: In a recent memo to clients, the law firm Bergeson & Campbell calls the announcement of the algae guide update "hugely important for the industrial biotechnology communities," adding that "EPA's announcement suggests a broader Agency initiative is underway, and is best read in the context of other relevant ... read more >
 1 2 >  View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Ave, N.W. Suite 100W
Washington, D.C. 20037
(202) 557-3800 • (202) 557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy and Terms of Use | Attorney Advertising | Trademarks
©2017 Bergeson & Campbell, P.C.
All Rights Reserved.